Right ventricular (RV) failure continues to be a major cause of morbidity and mortality after left ventricular assist device (LVAD) implantation. Preoperative evaluation of RV function with a variety of clinical, laboratory, echocardiographic, and hemodynamic variables is essential to ensure appropriate patient selection for LVAD therapy but remains imperfect. Therefore, clinicians involved in the care of these patients need to be prepared to manage RV failure after LVAD placement. Perioperative management of RV failure after LVAD implantation requires minimization of intraoperative RV ischemia, maintenance of appropriate filling pressure, supportive therapy with pulmonary vasodilators and inotropes, and surgical interventions such as RV assist devices in select cases. This article reviews the incidence of RV failure with LVAD implantation, preoperative predictors of RV failure, and perioperative management strategies.
KirklinJKNaftelDCKormosRL. The fourth INTERMACS annual report: 4,000 implants and counting. J Heart Lung Transplant. 2012;31:117-126.
2.
KormosRLTeutebergJJPaganiFD. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139:1316-1324.
3.
DrakosSGJanickiLHorneBD. Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol. 2010;105:1030-1035.
4.
DangNCTopkaraVKMercandoM. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant. 2006;25:1-6.
5.
MorganJAJohnRLeeBJOzMCNakaY. Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann Thorac Surg. 2004;77:859-863.
6.
PatelNDWeissESSchafferJ. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices. Ann Thorac Surg. 2008;86:832-840.
7.
JohnRLiaoKKamdarFEckmanPBoyleAColvin-AdamsM. Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices. J Thorac Cardiovasc Surg. 2010;140:447-452.
8.
EtzCDWelpHATjanTD. Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices. Ann Thorac Surg. 2007;83:1697-1705.
9.
OchiaiYMcCarthyPMSmediraNG. Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation. 2002;106:I-198-I-202.
10.
FukamachiKMcCarthyPMSmediraNGVargoRLStarlingRCYoungJB. Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann Thorac Surg. 1999;68:2181-2184.
11.
CowgerJSundareswaranKRogersJG. Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score. J Am Coll Cardiol. 2013;61:313-321.
12.
FarrarDJHillJDPenningtonDG. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg. 1997;113:202-209.
13.
FitzpatrickJR3rdFrederickJRHsuVM. Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant. 2008;27:1286-1292.
14.
KavaranaMNPessin-MinsleyMSUrtechoJ. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg. 2002;73:745-750.
15.
LietzKLongJWKfouryAG. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007;116:497-505.
16.
MatthewsJCKoellingTMPaganiFDAaronsonKD. The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol. 2008;51:2163-2172.
17.
KatoTSChokshiASinghP. Markers of extracellular matrix turnover and the development of right ventricular failure after ventricular assist device implantation in patients with advanced heart failure. J Heart Lung Transplant. 2012;31:37-45.
18.
HennigFStepanenkoAVLehmkuhlHB. Neurohumoral and inflammatory markers for prediction of right ventricular failure after implantation of a left ventricular assist device. Gen Thorac Cardiovasc Surg. 2011;59:19-24.
19.
KukuckaMStepanenkoAPotapovEKrabatschTKuppeHHabazettlH. Impact of tricuspid valve annulus dilation on mid-term survival after implantation of a left ventricular assist device. J Heart Lung Transplant. 2012;31:967-971.
20.
PotapovEVStepanenkoADandelM. Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device. J Heart Lung Transplant. 2008;27:1275-1281.
21.
PuwanantSHamiltonKKKlodellCT. Tricuspid annular motion as a predictor of severe right ventricular failure after left ventricular assist device implantation. J Heart Lung Transplant. 2008;27:1102-1107.
22.
TopilskyYOhJKShahDK. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation. JACC Cardiovasc Imaging. 2011;4:211-222.
23.
KukuckaMStepanenkoAPotapovE. Right-to-left ventricular end-diastolic diameter ratio and prediction of right ventricular failure with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2011;30:64-69.
24.
GrantADSmediraNGStarlingRCMarwickTH. Independent and incremental role of quantitative right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation. J Am Coll Cardiol. 2012;60:521-528.
25.
WangYSimonMABondeP. Decision tree for adjuvant right ventricular support in patients receiving a left ventricular assist device. J Heart Lung Transplant. 2012;31:140-149.
26.
TeutebergJJEwaldGAAdamsonRM. Risk assessment for continuous flow left ventricular assist devices: does the destination therapy risk score work? An analysis of over 1,000 patients. J Am Coll Cardiol. 2012;60:44-51.
27.
SubramaniamKYaredJP. Management of pulmonary hypertension in the operating room. Semin Cardiothorac Vasc Anesth. 2007;11:119-136.
28.
SlaughterMSPaganiFDRogersJG; HeartMate II Clinical Investigators. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29(4 suppl):S1-S39.
29.
KukuckaMPotapovEStepanenkoA. Acute impact of left ventricular unloading by left ventricular assist device on the right ventricle geometry and function: effect of nitric oxide inhalation. J Thorac Cardiovasc Surg. 2011;141:1009-1014.
30.
GeorgeIXydasSTopkaraVK. Clinical indication for use and outcomes after inhaled nitric oxide therapy. Ann Thorac Surg. 2006;82:2161-2169.
31.
WagnerFDandelMGuntherG. Nitric oxide inhalation in the treatment of right ventricular dysfunction following left ventricular assist device implantation. Circulation. 1997;96:II-291-II-296.
32.
ArgenzianoMChoudhriAFMoazamiN. Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg. 1998;65:340-345.
33.
De WetCJAffleckDGJacobsohnE. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery. J Thorac Cardiovasc Surg. 2004;127:1058-1067.
34.
AugoustidesJGOchrochEA. Pro: inhaled prostaglandin as a pulmonary vasodilator instead of nitric oxide. J Cardiothorac Vasc Anesth. 2005;19:400-402.
35.
DicksteinML. Con: inhaled prostaglandin as a pulmonary vasodilator instead of nitric oxide. J Cardiothorac Vasc Anesth. 2005;19:403-405.
36.
KlodellCTJrMoreyTELobatoEB. Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devices. Ann Thorac Surg. 2007;83:68-71.
37.
TedfordRJHemnesARRussellSD. PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail. 2008;1:213-219.
38.
SaeedDKidambiTShalliS. Tricuspid valve repair with left ventricular assist device implantation: is it warranted?J Heart Lung Transplant. 2011;30:530-535.
39.
KrishanKNairAPinneySAdamsDHAnyanwuAC. Liberal use of tricuspid-valve annuloplasty during left-ventricular assist device implantation. Eur J Cardiothorac Surg. 2012;41:213-217.
40.
PiacentinoV3rdGanapathiAMStafford-SmithM. Utility of concomitant tricuspid valve procedures for patients undergoing implantation of a continuous-flow left ventricular device. J Thorac Cardiovasc Surg. 2012;144:1217-1221.
41.
StulakJMRomansTCowgerJ. Delayed sternal closure does not increase late infection risk in patients undergoing left ventricular assist device implantation. J Heart Lung Transplant. 2012;31:1115-1119.
42.
FitzpatrickJR3rdFrederickJRHiesingerW. Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device. J Thorac Cardiovasc Surg. 2009;137:971-977.
43.
BhamaJKKormosRLToyodaYTeutebergJJMcCurryKRSiegenthalerMP. Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. J Heart Lung Transplant. 2009;28:971-976.
44.
JohnRLongJWMasseyHT. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg. 2011;141:932-939.
45.
KapurNKParuchuriVKorabathinaR. Effects of a percutaneous mechanical circulatory support device for medically refractory right ventricular failure. J Heart Lung Transplant. 2011;30:1360-1367.
46.
TakagakiMWurzerCWadeR. Successful conversion of TandemHeart left ventricular assist device to right ventricular assist device after implantation of a HeartMate XVE. Ann Thorac Surg. 2008;86:1677-1679.
47.
SugikiHNakashimaKVermesELoisanceDKirschM. Temporary right ventricular support with Impella Recover RD axial flow pump. Asian Cardiovasc Thorac Ann. 2009;17:395-400.
48.
HetzerRKrabatschTStepanenkoAHennigEPotapovEV. Long-term biventricular support with the HeartWare implantable continuous flow pump. J Heart Lung Transplant. 2010;29:822-824.
49.
StrueberMMeyerALMalehsaDHaverichA. Successful use of the HeartWare HVAD rotary blood pump for biventricular support. J Thorac Cardiovasc Surg. 2010;140:936-937.
50.
LoforteAMontaltoADella MonicaPLContentoCMusumeciF. Biventricular support with the HeartWare implantable continuous flow pump: an additional contribution. J Heart Lung Transplant. 2010;29:1443-1444.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
